Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
18667 | 475 | 28.7 | 40% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
157 | 21931 | BENIGN PROSTATIC HYPERPLASIA//PROSTATE CANCER//PROSTATE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | FOSFESTROL | Author keyword | 3 | 50% | 1% | 4 |
2 | IDIOPATHIC URETHRITIS | Author keyword | 1 | 100% | 0% | 2 |
3 | 5 ALPHA ANDROSTANEDIOL | Author keyword | 1 | 50% | 0% | 1 |
4 | BROMOMETRY | Author keyword | 1 | 50% | 0% | 1 |
5 | CELL ATTACHMENT AND SPREADING | Author keyword | 1 | 50% | 0% | 1 |
6 | DRUG ADMINISTRATION SCHEDULES | Author keyword | 1 | 50% | 0% | 1 |
7 | DUNNING R3327 | Author keyword | 1 | 50% | 0% | 1 |
8 | ESTRADIOL BINDING PROTEIN | Author keyword | 1 | 50% | 0% | 1 |
9 | HYDROXYSTEROID OXIDOREDUCTASE | Author keyword | 1 | 50% | 0% | 1 |
10 | KINASE RENATURATION | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXPRESS ESTROGEN | 2 | 67% | 0% | 2 |
2 | PSEUDOMEMBRANOUS TRIGONITIS | 2 | 67% | 0% | 2 |
3 | URETHRORRHAGIA | 2 | 67% | 0% | 2 |
4 | NUCLEAR ANDROGEN RECEPTOR | 1 | 100% | 0% | 2 |
5 | R 3327 | 1 | 50% | 0% | 2 |
6 | HIGH DOSE MEDROXYPROGESTERONE | 1 | 40% | 0% | 2 |
7 | IMMOBILON | 1 | 50% | 0% | 1 |
8 | PEROXIDASE ANTIPEROXIDASE METHOD | 1 | 50% | 0% | 1 |
9 | RALOXIFENE LY156758 | 1 | 50% | 0% | 1 |
10 | GASTROSTOMY BUTTON | 1 | 20% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
PHYSIOLOGICAL-BASIS OF ENDOCRINE THERAPY FOR PROSTATIC-CANCER | 1991 | 40 | 62 | 31% |
HORMONAL-THERAPY OF PROSTATIC-CARCINOMA - IS THERE A RATIONALE FOR DELAYED TREATMENT | 1986 | 14 | 12 | 50% |
Apoptosis and other mechanisms in androgen ablation treatment and androgen independent progression of prostate cancer: A review | 1998 | 17 | 100 | 7% |
DNA methylation of nuclear receptor genes - possible role in malignancy | 2002 | 20 | 93 | 5% |
CANCER OF THE PROSTATE - ENDOCRINE FACTORS | 1987 | 16 | 129 | 20% |
The multiple applications of tamoxifen: an example pointing to SERM modulation being the aspirin of the 21(st) century | 2008 | 10 | 45 | 4% |
THE APPLICATION OF STEROID-RECEPTOR ASSAY IN HUMAN-PROSTATE CANCER-RESEARCH AND CLINICAL MANAGEMENT (REVIEW) | 1982 | 22 | 13 | 54% |
THE PROSTATE AND MALE-HORMONES AFTER 50 YEARS OF AGE | 1988 | 1 | 39 | 18% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED INTERNAL MED 3 MINAMI KU | 1 | 50% | 0.2% | 1 |
2 | NEPHROL SECRETARY OFF | 1 | 50% | 0.2% | 1 |
3 | WOLMARANS | 1 | 50% | 0.2% | 1 |
4 | MOLEC ENDOCRINOL UNIT | 0 | 20% | 0.2% | 1 |
5 | CANC GENOA | 0 | 11% | 0.2% | 1 |
6 | EXPT MED SURG UROL | 0 | 100% | 0.2% | 1 |
7 | MED HORMONE BIOCHEM | 0 | 100% | 0.2% | 1 |
8 | MED HORMONE BIOCHEM S | 0 | 100% | 0.2% | 1 |
9 | SURG UROL REPROD MED | 0 | 100% | 0.2% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000223466 | PROSTATE DEVELOPMENT//BIOL SCI VET MED//PROSTATE STEM CELL |
2 | 0.0000168676 | CORNCOB BEDDING//TYPE II SITES//TYPE II ESTROGEN BINDING SITES |
3 | 0.0000166790 | TZP 4238//CHLORMADINONE ACETATE CMA//PREVENTION OF ESTRUS |
4 | 0.0000157784 | 5 ALPHA REDUCTASE//FINASTERIDE//BIOL SYST ANIM PROD |
5 | 0.0000143237 | ESTRAMUSTINE BINDING PROTEIN//ESTRAMUSTINE//ESTROMUSTINE |
6 | 0.0000127737 | SHIONOGI CARCINOMA 115//VITAMIN B 12B//CLIN EXPT PATHOPHYSIOL |
7 | 0.0000110919 | PROSTATIC ACID PHOSPHATASE//SECT UROL SURG//PROSTATIC PHOSPHATASE |
8 | 0.0000092411 | ESTROGEN RECEPTOR ACTIVATION FACTOR//NUCLEAR ESTROGEN RECEPTOR II//NON ACTIVATED ESTROGEN RECEPTOR |
9 | 0.0000086743 | NKX31//LOBUND//3 2 DIMETHYL 4 AMINOBIPHENYL |
10 | 0.0000082086 | ANDROGEN DEPRIVATION THERAPY//INTERMITTENT ANDROGEN SUPPRESSION//BICALUTAMIDE |